Tysabri Lawyers

Tysabri (natalizumab) is a drug used to treat relapsing multiple sclerosis (MS) and Crohn’s disease in adults. Approximately 30,000 patients are currently on Tysabri. Marketed by Biogen Idec and Irish drugmaker Elan, the drug was temporarily discontinued in 2005 after three patients participating in clinical trials developed progressive multifocal leukoencephalopathy (PML), a rare but potentially deadly brain infection.

In February, the U.S. Food and Drug Administration warned that some patients taking Tysabri developed “clinically significant” signs of serious liver damage less than a week after their first dose. Several months later, two new cases of PML in Tysabri patients were reported, re-emphasizing the serious health risks associated with taking the drug.

In the interest of promoting public health and safety, Tysabri lawyers Pulaski & Middleman are closely monitoring developments.

Tysabri and Progressive Multifocal Leukoencephalopathy (PML)

A rare viral infection of the brain, PML is a progressive demyelinating disease, meaning that it slowly destroys the myelin sheath surrounding the nerve cells in the brain. Patients taking Tysabri are at an increased risk of developing PML.

Most patients die less than five months after PML appears.

Symptoms of PML include:

  • Weakness or paralysis
  • Ataxia (loss of muscle control)
  • Loss of vision
  • Mental/cognitive deterioration
  • Speech impairment
  • Death
For more information on PML, contact Tysabri PML lawyers Pulaski & Middleman at 800-223-3784.

Tysabri and Severe Liver Damage

According to product safety warnings released by the FDA, patients taking Tysabri are at risk of sustaining serious liver damage. Clinical signs of this damage can appear as early as a week after the first dose of Tysabri; severe damage may lead to death or require a liver transplant.

People taking Tysabri are encouraged to contact a doctor and consult with Tysabri attorneys Pulaski & Middleman at 800-223-3784 if you experience any of these symptoms of liver damage:

  • Nausea
  • Stomach pain
  • Dark-colored urine
  • Jaundice (yellow skin)
  • Loss of appetite

Contact Pulaski & Middleman

The law firm of Pulaski & Middleman is dedicated to representing people who have been injured by defective or dangerous drugs. If you have developed PML or sustained liver damage as a result of taking Tysabri, call Tysabri side effects lawyers Pulaski & Middleman at 1-800-223-3784 today.





















© Copyright 2007-2012 Pulaski & Middleman L.L.C., Houston | Disclaimer | Terms of Use | Resources | Call Today 800.BAD.DRUG or 800.223.3784.

Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Pulaski & Middleman's primary office is located in Houston. The attorney responsible for the content of this web site is Adam Pulaski.

Search Engine Optimization provided by the Search Engine Optimization firm The Search Engine Guys.